Berkeley Lights’ Technology and Platforms are Re-Defining Speed, Efficiency, and Insight in These Emerging Applications.
CELL THERAPY MANUFACTURING
Berkeley Lights’ cross-functional teams of biologists and engineers are working on ways our technology can create fully-automated processes for cell therapy manufacturing, including autologous (patient-derived) and allogeneic (donor-derived) cell therapies. Partner with us in our SearchLight Solutions program to advance these exciting applications.
Berkeley Lights’ technology has many Synthetic Biology applications beyond mammalian cells and antibodies. Through Lightspeed Development Services, we can help you find efficient ways to program both mammalian and non-mammalian cells like yeast and filamentous fungi to produce valuable proteins and other substances.
EMERGING PATHOGEN THERAPEUTICS
Epidemics caused by emerging viruses are an ongoing threat to global health. Our Beacon® platform can be used to screen patients who have survived viral outbreaks and rapidly find the virus-fighting antibodies in their systems, moving us toward life-saving disease therapies much more quickly.
To meet the world’s agricultural needs, plant productivity and disease resistance need to advance dramatically. With Berkeley Lights’ OptoSelect™ chips functioning as mini-greenhouses, we can identify useful changes rapidly, potentially speeding up agricultural workflows from years to months.
HUMAN REPRODUCTIVE MANAGEMENT
By working with individual cells and embryos, Berkeley Lights’ technology can lower costs and expand access for families that need in vitro fertilization. Lightspeed Development Services can partner with you to improve your in vitro processes.
Our Beacon platform is perfectly suited for discovering and monitoring biomarkers in a variety of therapeutic areas—from live fetal cell screening in maternal blood to circulating tumor cells. Partner with us to define how our technology can accelerate Cellular Diagnostics.